Early GLP-1 manufacturers, including Novo Nordisk and Eli Lilly, originally developed the drug to help with blood sugar control in adults with type 2 diabetes, but weight loss has since become the primary driver of adoption, he says

Knowing how to manage them can help you stay comfortable and adherent to treatment: For nausea and digestive discomfort: Eat smaller, more frequent meals Limit ultra-processed foods and takeaways Stay well hydrated (2-3 litres a day) Consider ginger tea or supplements (shown to help in clinical settings) Avoid lying down immediately after eating For fatigue: Ensure adequate protein intake Maintain electrolyte balance by eating a diet based on whole foods (supplements not necessary unless prescribed) Prioritise 7-8 hours of sleep Consider timing your injection before bed if daytime fatigue is significant In clinical trials, approximately 65% of participants experienced at least one side effect during the first month, but this dropped significantly by month three as the body adjusted 1
Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ
The ability of GLP1RAs to improve glycaemic control in addition to achieving weight loss means they are potentially a good candidate for improving outcomes in women who have obesity and GDM/diabetes before or during pregnancy, and the long-term health of their offspring